Clinical trial researches immunotherapy for recurrent thymoma and thymic carcinoma

stock image of doctor with patient

Image credit: iStock

Thymoma and thymic carcinoma are types of cancer that occur in the thymus, a specialized primary lymphoid organ of the immune system. A clinical trial led by Arun Rajan, M.D., Senior Clinician in the Thoracic and GI Malignancies Branch, is researching immunotherapy and other immunomodulatory treatments for the diseases. The trial will take place at the NIH Clinical Center in Bethesda, Maryland, and there is no cost for participation.

For more information, please contact Shannon Swift at (240) 858-3157 or identifier: NCT05104736

NCI Protocol ID: NCI000317

Official Title: A Phase II, Open-Label Trial of PT-112 in Subjects With Thymoma and Thymic Carcinoma

The Center for Cancer Research is NCI’s internal cancer center, a publicly funded organization working to improve the lives of cancer patients by solving important, challenging and neglected problems in cancer research and patient care. Highly trained physician-scientists develop and carry out clinical trials to create the medicines of tomorrow treating patients at the world’s largest dedicated research hospital on the campus of the National Institutes of Health in Bethesda, Maryland.  

For more information on CCR clinical trials click here, and subscribe to have the latest CCR clinical trials sent directly to your inbox.

Posted on Tue, 06/21/2022